Alpha Teknova (TKNO) Non Operating Income (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Non Operating Income came in at -$210000.0 in Q1 2026, down 161.58% year-on-year from $341000.0 in Q1 2025, and little changed on a QoQ basis from -$211000.0 in Q4 2025.
Alpha Teknova (TKNO) Non Operating Income (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Non Operating Income data on file, last reported at -$210000.0 in Q1 2026.
- On a quarterly basis, Non Operating Income fell 161.58% year-over-year to -$210000.0 in Q1 2026; TTM through Mar 2026 was -$776000.0, a 286.07% decrease from a year earlier, with the FY2025 full-year figure at -$225000.0, up 67.25% from the prior year.
- Non Operating Income for Q1 2026 stood at -$210000.0, roughly flat from -$211000.0 in the prior quarter.
- Over the last five years, Non Operating Income for TKNO reached as high as $341000.0 in Q1 2025 and fell as low as -$1.4 million in Q3 2023.
- Historically, Non Operating Income has averaged -$139352.9 across 5 years, with a median of -$141000.0 in 2024.
- On a YoY basis, Non Operating Income climbed as much as 953.85% in 2023 and fell as far as 1403.77% in 2023.
- Year by year, Non Operating Income stood at $147000.0 in 2022, then plunged by 169.39% to -$102000.0 in 2023, then dropped by 26.47% to -$129000.0 in 2024, then slumped by 63.57% to -$211000.0 in 2025, then advanced by 0.47% to -$210000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$210000.0 in Q1 2026, -$211000.0 in Q4 2025, and -$190000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | -210,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -210,000.00 |
| Dec 31, 2025 | -211,000.00 |
| Sep 30, 2025 | -190,000.00 |
| Jun 30, 2025 | -165,000.00 |
| Mar 31, 2025 | 341,000.00 |
| Dec 31, 2024 | -129,000.00 |
| Sep 30, 2024 | -141,000.00 |
| Jun 30, 2024 | -272,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | -102,000.00 |
| Sep 30, 2023 | -1.38 Mn |
| Jun 30, 2023 | -142,000.00 |
| Mar 31, 2023 | 111,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | 106,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | -74,000.00 |
| Sep 30, 2021 | -255,000.00 |
| Jun 30, 2021 | -307,000.00 |